Literature DB >> 10690337

Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?

M E Sullivan1, C S Thompson, M R Dashwood, M A Khan, J Y Jeremy, R J Morgan, D P Mikhailidis.   

Abstract

There is convincing evidence that the prevalence of erectile dysfunction is increased among men with ischaemic heart disease. This association may be attributed to the fact that both erectile dysfunction and ischaemic heart disease share similar risk factors (e.g. hypertension, dyslipidaemia, diabetes and smoking). Nitric oxide (NO) activity is adversely affected, in penile and vascular tissue, by these risk factors. It is therefore not surprising that a defect in NO activity is thought to play a role in the pathogenesis of both erectile dysfunction and ischaemic heart disease. We consider this evidence and propose that defective NO activity provides a unifying explanation for the association between these two conditions. Further research in this area may improve our understanding of the pathogenesis of cardiovascular diseases as a whole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10690337     DOI: 10.1016/s0008-6363(99)00135-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  44 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

3.  Pharmacologic treatment of erectile dysfunction.

Authors:  William D Steers
Journal:  Rev Urol       Date:  2002

Review 4.  Iron and a Man's Reproductive Health: the Good, the Bad, and the Ugly.

Authors:  J Scott Gabrielsen; Dolores J Lamb; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2018-06-01       Impact factor: 3.092

5.  Folic acid administration reduces neointimal thickening, augments neo-vasa vasorum formation and reduces oxidative stress in saphenous vein grafts from pigs used as a model of diabetes.

Authors:  J Bloor; N Shukla; F C T Smith; G D Angelini; J Y Jeremy
Journal:  Diabetologia       Date:  2010-02-25       Impact factor: 10.122

Review 6.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

7.  Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes.

Authors:  Nicola Caretta; Saula Vigili de Kreutzenberg; Umberto Valente; Gabriella Guarneri; Alberto Ferlin; Angelo Avogaro; Carlo Foresta
Journal:  Endocrine       Date:  2016-01-12       Impact factor: 3.633

Review 8.  Change in Sexual Dysfunction Following Bariatric Surgery.

Authors:  Laura R Wingfield; Myutan Kulendran; Georgia Laws; Harvinder Chahal; Samantha Scholtz; Sanjay Purkayastha
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

Review 9.  Etiology and treatment of erectile failure in diabetes mellitus.

Authors:  Donald Richardson; Aaron Vinik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

10.  Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men.

Authors:  Arie Roth; Ofra Kalter-Leibovici; Yehuda Kerbis; Ella Tenenbaum-Koren; Juza Chen; Tamar Sobol; Itamar Raz
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.